Hematology & Oncology Doctors in Summit, NJ Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Dr. Sophie D Morse, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-608-0078

Dr. Neil Morganstein, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, The Cancer Center At Overlook, Summit, NJ 07901 Phone: 908-608-0078    Fax: 908-608-1504

Dr. Paul Markowski, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-608-0078

Jeffrey Alan Jones, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 86 Morris Ave, Summit, NJ 07901 Phone: 908-673-9686

Dr. Rujuta Saksena, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-608-0078    Fax: 908-608-1504

Dr. Bonni Lee Guerin, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, The Cancer Center At Overlook, Summit, NJ 07901 Phone: 908-608-0078    Fax: 908-608-1504

John S Kauh, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 42 Club Dr, Summit, NJ 07901 Phone: 678-362-6334

News Archive

Microbial community less stable and less diverse in antibiotic-treated children

The DIABIMMUNE project followed the development of 39 Finnish infants from birth to the age of three. Half of the children received 9-15 antibiotic treatments during the research period, and the other half did not receive any such treatments.

FDA approves Inspire to begin STAR clinical trial to evaluate UAS therapy for OSA

Inspire Medical Systems, a leading developer of neuro-stimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today that the company has received approval from the U.S. Food and Drug Administration (FDA) to begin its STAR pivotal clinical trial. The STAR trial (Stimulation Therapy for Apnea Reduction), is a multi-center study that will evaluate both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy in patients with moderate to severe obstructive sleep apnea (OSA).

MRCC deploys CTT's Calmare Pain Therapy Treatment medical device

Competitive Technologies, Inc. announced that McKinney Regional Cancer Care Center, a private physician oncology practice based in McKinney, TX, is the first cancer center in Texas treating with CTT's Calmare Pain Therapy Treatment medical device. Patients suffering from pain related to cancer are being treated under the direction of medical oncologist Dennis Birenbaum, M.D.

Diets rich in potassium may help prevent heart and kidney problems in patients with type 2 diabetes

Diets rich in potassium may help protect the heart and kidney health of patients with type 2 diabetes, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

Improvement in application of health information technology needed for better patient care

The break neck pace of genomic discoveries has ushered in a new problem in the delivery of personalized medicine: comprehensive and consistent data reporting that will improve health information technologies for better patient care.

Read more Medical News

› Verified 6 days ago